Literature DB >> 16538071

Hypercalcemia in the emergency department.

Chien-Te Lee1, Chih-Chao Yang, King-Kwan Lam, Chia-Te Kung, Chia-Jung Tsai, Hung-Chun Chen.   

Abstract

BACKGROUND: Severe hypercalcemia can be life-threatening. However, its incidence and the underlying causes in the emergency department (ED) have not been determined. In the present study, we investigated these issues and the impacts on renal function and patients' survival.
METHODS: We performed a retrospective study to analyze the patients with hypercalcemia in the ED for 1 year. Serum total calcium level greater than 10.3 mg/dL was defined as hypercalcemia.
RESULTS: During the study period, 321 of 4293 patients (7.5%) were found to have hypercalcemia (serum calcium 11.7 +/- 1.6 mg/dL). Most of them had mild hypercalcemia (calcium level < 12.0 g/dL, 70.7%). Malignancy (36.4%) and uremia (32.4%) were the most common underlying causes. Normal renal function was observed in only 75 (23.4%) of all patients with hypercalcemia. The total mortality rate was 23.1%, and death was associated with male gender, higher calcium level, lower hemoglobin, and malignancy (all P < 0.05). Logistic analysis found that serum calcium and hemoglobin levels were independent risk factors for mortality.
CONCLUSIONS: Severe hypercalcemia is frequently and life-threatening in the ED. Therefore routine determination of serum calcium level is recommended, and immediate therapy should be initiated to treat the patients at high risk.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16538071     DOI: 10.1097/00000441-200603000-00002

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  7 in total

1.  47-year-old woman with dizziness, weakness, and confusion.

Authors:  Rozalina Grubina; David L Klocke
Journal:  Mayo Clin Proc       Date:  2011-01       Impact factor: 7.616

2.  Calcium levels on admission and before discharge are associated with mortality risk in hospitalized patients.

Authors:  Amit Akirov; Alexander Gorshtein; Ilana Shraga-Slutzky; Ilan Shimon
Journal:  Endocrine       Date:  2017-06-30       Impact factor: 3.633

Review 3.  Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment.

Authors:  Peter J Tebben; Ravinder J Singh; Rajiv Kumar
Journal:  Endocr Rev       Date:  2016-09-02       Impact factor: 19.871

Review 4.  Recovery of paraneoplastic hypercalcemia by sunitinib treatment for renal cell carcinoma: a case report and review of the literature.

Authors:  Halit Karaca; Ayhan Lale; Mustafa Dikilitas; Metin Ozkan; Ozlem Er
Journal:  Med Oncol       Date:  2009-10-15       Impact factor: 3.064

5.  Possible improvement of survival with use of zoledronic acid in patients with bone metastases from renal cell carcinoma.

Authors:  Yosuke Yasuda; Yasuhisa Fujii; Takeshi Yuasa; Shinichi Kitsukawa; Shinji Urakami; Shinya Yamamoto; Junji Yonese; Shunji Takahashi; Iwao Fukui
Journal:  Int J Clin Oncol       Date:  2012-09-11       Impact factor: 3.402

Review 6.  Renal cell carcinoma presenting with paraneoplastic hypercalcemic coma: a case report and review of the literature.

Authors:  Kara Pepper; Uraporn Jaowattana; Michael D Starsiak; Raghuueer Halkar; Kelly Hornaman; Wenli Wang; Priya Dayamani; Vin Tangpricha
Journal:  J Gen Intern Med       Date:  2007-04-19       Impact factor: 5.128

7.  Calcium Disorders in the Emergency Department: Independent Risk Factors for Mortality.

Authors:  Thomas C Sauter; Gregor Lindner; Sufian S Ahmad; Alexander Benedikt Leichtle; Georg-Martin Fiedler; Aristomenis K Exadaktylos; Dominik G Haider
Journal:  PLoS One       Date:  2015-07-14       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.